Overall Health, Daily Functioning, and Quality of Life in Acute Hepatic Porphyria Patients: ENVISION, a Phase 3 Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

• Published in: Digestive and liver disease 2020-02, Vol.52, p.e35-e35
• Main Authors: Sardh, E., Gouya, L., Rees, D.C., Stein, P., Stölzel, U., Aguilera Peiro, P., Bissell, D.M., Bonkovsky, H.L., Keel, S., Parker, C., Phillips, J.D., Silver, S., Windyga, J., D’Avola, D., Ross, G., Stewart, P., Ritchie, B., Oh, J., Harper, P., Wang, J.D., Langendonk, J.G., Ivanova, A., Horie, Y., Anderson, K.E., Ventura, P., Kauppinen, R., Vassiliou, D., Wang, B., Hother-Nielsen, O., Nakahara, T., Lee, M.J., Sasapu, A., Scalera, S., Lin, T., Penz, C., Simon, A., Ko, J., Balwani, M.
• Format: Article
• Language: English
• ISSN: 1590-8658; 1878-3562
• DOI: 10.1016/j.dld.2019.12.123